Hebbrecht has developed nanobodies that target N-WASP, modulating the N-WASP-Arp2/3 complex interaction, thereby reducing invasive pseudopod formation and matrix degradation during PCa invasion (Hebbrecht et al., 2017). The gene discussed is ACTR2; the disease is posterior cortical atrophy.